These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15756629)

  • 21. Salmeterol and fluticasone in young children with multiple-trigger wheeze.
    Mäkelä MJ; Malmberg LP; Csonka P; Klemola T; Kajosaari M; Pelkonen AS
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):65-70. PubMed ID: 22727160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
    You-Ning L; Humphries M; Du X; Wang L; Jiang J
    Int J Clin Pract; 2005 Jul; 59(7):754-9. PubMed ID: 15963199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
    Wouters EF; Postma DS; Fokkens B; Hop WC; Prins J; Kuipers AF; Pasma HR; Hensing CA; Creutzberg EC;
    Thorax; 2005 Jun; 60(6):480-7. PubMed ID: 15923248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler.
    Masoli M; Weatherall M; Ayling J; Williams M; Beasley R
    Respir Med; 2005 May; 99(5):545-52. PubMed ID: 15823450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma.
    Pearlman D; Qaqundah P; Matz J; Yancey SW; Stempel DA; Ortega HG
    Pediatr Pulmonol; 2009 May; 44(5):429-35. PubMed ID: 19382218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.
    Fardon T; Haggart K; Lee DK; Lipworth BJ
    Respir Med; 2007 Jun; 101(6):1218-28. PubMed ID: 17178217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.
    Jarjour NN; Wilson SJ; Koenig SM; Laviolette M; Moore WC; Davis WB; Doherty DE; Hamid Q; Israel E; Kavuru MS; Ramsdell JW; Tashkin DP; Reilly DS; Yancey SW; Edwards LD; Stauffer JL; Dorinsky PM; Djukanovic R
    J Allergy Clin Immunol; 2006 Jul; 118(1):44-52. PubMed ID: 16815137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
    Koopmans JG; Lutter R; Jansen HM; van der Zee JS
    J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of the combination of fluticasone propionate and salmeterol in patients with moderate persistent asthma within a "real-life" setting.
    Trautmann M; Banik N; Tews JT; Jörres RA; Nowak D
    Eur J Med Res; 2007 Jun; 12(6):255-63. PubMed ID: 17666315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.
    Koopmans JG; Lutter R; Jansen HM; van der Zee JS
    Thorax; 2006 Apr; 61(4):306-12. PubMed ID: 16449264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH; Wong E; Blitz S; Diner B; Mackey D; Ross S; Senthilselvan A
    Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma.
    Li HT; Zhang TT; Zhou H; Qu XJ; Wu WM; Huang J
    Respiration; 2007; 74(1):33-43. PubMed ID: 17008769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The response to combination therapy treatment regimens in severe/difficult-to-treat asthma.
    Campbell JD; Borish L; Haselkorn T; Rasouliyan L; Lee JH; Wenzel SE; Sullivan SD;
    Eur Respir J; 2008 Nov; 32(5):1237-42. PubMed ID: 18684845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of asthma compliance enhancement training on asthma control in patients on combination therapy with salmeterol/fluticasone propionate: a randomised controlled trial.
    Ulrik CS; Claudius BK; Tamm M; Harving H; Siersted HC; Backer V; Hellquist B; Dahl R; Høgholm A; Jøhnk IK
    Clin Respir J; 2009 Jul; 3(3):161-8. PubMed ID: 20298399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
    Stempel DA; Riedel AA; Carranza Rosenzweig JR
    Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of regular treatment with combination of salmeterol/fluticasone propionate and salmeterol alone in cough variant asthma.
    Tagaya E; Kondo M; Kirishi S; Kawagoe M; Kubota N; Tamaoki J
    J Asthma; 2015 Jun; 52(5):512-8. PubMed ID: 25329681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.
    Masoli M; Weatherall M; Holt S; Beasley R
    Thorax; 2005 Sep; 60(9):730-4. PubMed ID: 16135679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
    Sorkness CA; Lemanske RF; Mauger DT; Boehmer SJ; Chinchilli VM; Martinez FD; Strunk RC; Szefler SJ; Zeiger RS; Bacharier LB; Bloomberg GR; Covar RA; Guilbert TW; Heldt G; Larsen G; Mellon MH; Morgan WJ; Moss MH; Spahn JD; Taussig LM;
    J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
    J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.